Skip to content
CorpDev.Org

CorpDev.Org

Daily News for Dealmakers

Friday 23rd May 2025
  • M&A/ PE Advisory
  • AI Assisted Due Diligence
  • Private Equity
  • Tech, Media & Telecom
  • Financial Services
  • Healthcare & Life Sciences
  • Consumer & Industrial
  • Energy & Utilities
CorpDev.Org

CorpDev.Org

Daily News for Dealmakers

  • M&A/ PE Advisory
  • AI Assisted Due Diligence
  • Private Equity
  • Tech, Media & Telecom
  • Financial Services
  • Healthcare & Life Sciences
  • Consumer & Industrial
  • Energy & Utilities

Day: May 22, 2025

OpenAI’s $6.5B Gamble: How Jony Ive’s Acquisition Reshapes the AI-Hardware Frontier

OpenAI’s $6.5B Gamble: How Jony Ive’s Acquisition Reshapes the AI-Hardware Frontier

  • May 22, 2025
  • 0 Comments
  • By CorpDev
In a tectonic shift for the artificial intelligence industry, OpenAI has acquired legendary Apple designer Jony Ive's hardware startup io for $6.5 billion in an all-stock transaction . The deal...
Posted in Technology, Media and Telecom
AbbVie Secures Appellate Victory in Allergan Shareholder Litigation: Legal and Strategic Implications

AbbVie Secures Appellate Victory in Allergan Shareholder Litigation: Legal and Strategic Implications

  • May 22, 2025
  • 0 Comments
  • By CorpDev
An Illinois appellate panel affirmed the dismissal of a shareholder class action against AbbVie Inc. on May 21, 2025, resolving allegations that the biopharmaceutical giant issued unregistered...
Posted in Healthcare and Life Sciences
Tech CEOs Face Mounting Scrutiny Over Blockchain Fraud Schemes and Investor Deception

Tech CEOs Face Mounting Scrutiny Over Blockchain Fraud Schemes and Investor Deception

  • May 22, 2025
  • 0 Comments
  • By CorpDev
Federal prosecutors and regulators have intensified crackdowns on cryptocurrency executives accused of orchestrating elaborate frauds, with recent cases exposing $1.3 billion in losses through...
Posted in Technology, Media and Telecom
Sanofi’s $600 Million Strategic Acquisition of Vigil Neuroscience: Accelerating Alzheimer’s Innovation Through TREM2 Targeting

Sanofi’s $600 Million Strategic Acquisition of Vigil Neuroscience: Accelerating Alzheimer’s Innovation Through TREM2 Targeting

  • May 22, 2025
  • 0 Comments
  • By CorpDev
In a strategic move to strengthen its neurology pipeline, Sanofi announced on May 21, 2025, its definitive agreement to acquire Vigil Neuroscience for up to $600 million. The transaction centers on...
Posted in Healthcare and Life Sciences

Posts navigation

Newer posts

CorpDev.Org

24×7 real time deals updates for everyone associated with deals.  Bookmark the page!

Daily M&A/PE News In 5 Min

Recent Posts

  • HPS Orchestrates $3.4 Billion Private Credit Package for Consumer Cellular in GTCR-Led Dividend Recap
  • Strava’s Strategic Acquisitions: Building a Verticalized Fitness Ecosystem Through Runna and The Breakaway
  • Natixis Targets $1.5 Billion Private Credit Expansion Amid Global Market Transformation
  • Strategic Calculus: Dundee Precious Metals’ $935 Million Play for Adriatic Metals Reshapes European Mining Landscape
  • Private Equity at an Inflection Point: NFL Divestments, Liquidity Pressures, and European VC Resilience Reshape 2025 Landscape

Categories

  • M&A/ PE Advisory
  • AI Assisted Due Diligence
  • Private Equity
  • Tech, Media & Telecom
  • Financial Services
  • Healthcare & Life Sciences
  • Consumer & Industrial
  • Energy & Utilities

Daily M&A/PE News In 5 Min

Deals by month

  • May 2025 (126)
  • April 2025 (86)
  • January 2025 (53)
  • November 2024 (62)
  • October 2024 (102)
  • September 2024 (97)
  • August 2024 (165)
  • July 2024 (20)
  • March 2023 (7)
  • November 2022 (41)
  • October 2022 (89)
  • September 2022 (190)
  • August 2022 (80)
  • July 2022 (2)
  • June 2022 (79)
  • May 2022 (1)

Copyrights belong to 'Sources' referred to in each article, unless the articles are originally published by CorpDev.org in which case the copyright belongs to CorpDev.org